Search

Kent Matlack Phones & Addresses

  • 949 Hampshire St, San Francisco, CA 94110
  • 38 Madison St, Cambridge, MA 02140
  • 1100 Massachusetts Ave, Cambridge, MA 02138
  • 519 Washington St, Brookline, MA 02446
  • Somerville, MA
  • Boston, MA

Work

Company: Whitehead institute 2005 to 2012 Address: Cambridge, MA, USA Position: Staff scientist

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of California, San Francisco Specialities: Biochemistry

Skills

Molecular Biology • Biochemistry • Cell Biology • Cell Culture • Lifesciences • Protein Chemistry • Protein Expression • High Throughput Screening • Cell • Genomics • Biotechnology • Protein Purification • Drug Discovery • Assay Development • Network Administration

Industries

Biotechnology

Resumes

Resumes

Kent Matlack Photo 1

Senior Scientist Biochemistry And Program Manager Alzheimer's Disease

View page
Location:
660 King St, San Francisco, CA 94107
Industry:
Biotechnology
Work:
Whitehead Institute - Cambridge, MA, USA 2005 - 2012
Staff Scientist
Education:
University of California, San Francisco
Doctorates, Doctor of Philosophy, Biochemistry
Stanford University
Bachelors, Bachelor of Science, Chemistry
Skills:
Molecular Biology
Biochemistry
Cell Biology
Cell Culture
Lifesciences
Protein Chemistry
Protein Expression
High Throughput Screening
Cell
Genomics
Biotechnology
Protein Purification
Drug Discovery
Assay Development
Network Administration

Publications

Us Patents

Yeast Cells Expressing Amyloid Beta And Uses Therefor

View page
US Patent:
20130045483, Feb 21, 2013
Filed:
Jun 29, 2012
Appl. No.:
13/538089
Inventors:
SEBASTIAN TREUSCH - Lawrenceville NJ, US
KENT E.S. MATLACK - BROOKLINE MA, US
SUSAN L. LINDQUIST - Cambridge MA, US
Assignee:
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH - CAMBRIDGE MA
International Classification:
C12N 5/071
C12Q 1/68
C40B 30/06
C12N 1/19
C12N 5/10
US Classification:
435 613, 4352542, 435375, 435325, 435366, 506 10
Abstract:
Disclosed are yeast cells expressing a polypeptide comprising a signal sequence and a human amyloid beta protein. Also disclosed are methods of screening yeast cells to identify compounds that prevent or suppress amyloid beta-induced toxicity and genetic suppressors or enhancers of amyloid beta-induced toxicity. Compounds identified by such screens can be used to treat or prevent neurodegenerative disorders such as Alzheimer's disease.

Yeast Cells Expressing Amyloid Beta And Uses Therefor

View page
US Patent:
20130022988, Jan 24, 2013
Filed:
Jan 11, 2011
Appl. No.:
13/521966
Inventors:
Kent E.S. Matlack - Brookline MA, US
Susan L. Lindquist - Cambridge MA, US
Assignee:
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH - Cambridge MA
International Classification:
C12N 1/19
C12Q 1/68
C12Q 1/02
US Classification:
435 616, 4352542, 435 29
Abstract:
Disclosed are yeast cells expressing a polypeptide comprising a signal sequence and a human amyloid beta protein. Also disclosed are methods of screening yeast cells to identify compounds that prevent or suppress amyloid beta-induced toxicity and genetic suppressors or enhancers of amyloid beta-induced toxicity. Compounds identified by such screens can be used to treat or prevent neurodegenerative disorders such as Alzheimer's disease.
Kent E Matlack from San Francisco, CA, age ~64 Get Report